Contact
searchSearch
HMP Global
CRT 2026

Every Second Counts: The Critical Role of Nurses & Techs in Beating the Balloon Clock

06/04/2026

© 2026 Lumen Foundation. Authorized use only. Unauthorized reproduction or distribution of this video is strictly prohibited.

Hosted with permission from the Lumen Foundation.

STEMI: The Stakes

A video presentation by Sameer Mehta, MD, FACC, MBA, at the March 8th Nurse & Technologist Symposium at CRT 2026, held March 7-10 in Washington, D.C.

Dr. Mehta is Chairman, Lumen Foundation. 

He can be contacted at sameer.lumenglobal@gmail.com.

 

Dr. Mehta's Essential STEMI Takeaways

Dr. Mehta's important takeaways

 


Related Content

SCAI + SCCT Statement
New Consensus Statement Standardizes Use of CT-Derived FFR
06/04/2026
Published in JCCT and endorsed by the ACC, “Fractional flow reserve in coronary computed tomography angiography” provides evidence-based guidelines for the acquisition, interpretation and reporting of FFR-CT.
Published in JCCT and endorsed by the ACC, “Fractional flow reserve in coronary computed tomography angiography” provides evidence-based guidelines for the acquisition, interpretation and reporting of FFR-CT.
Published in JCCT and endorsed...
06/04/2026
Cath Lab Digest
Drug-Coated Balloons
Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment
06/02/2026
Advanced NanoTherapies (ANT)'s SirPlux Duo, a dual-drug device with sirolimus and paclitaxel that uses a proprietary nanoparticle delivery system to drive active cellular uptake within the vessel wall.
Advanced NanoTherapies (ANT)'s SirPlux Duo, a dual-drug device with sirolimus and paclitaxel that uses a proprietary nanoparticle delivery system to drive active cellular uptake within the vessel wall.
Advanced NanoTherapies (ANT)'s...
06/02/2026
Cath Lab Digest
ASC 6,000 milestone procedures
Arizona Centers
Arizona-Based Tri-City Cardiology's ASC Surpasses 6,000 Procedures, Marking a Major Milestone in Outpatient Cardiovascular Care
05/29/2026
"Delivering more than 6,000 procedures in an outpatient environment speaks to the strength of our team, the sophistication of our facility, and our commitment to cardiovascular treatment," said Bruce Stec, ASC administrator at Tri-City...
"Delivering more than 6,000 procedures in an outpatient environment speaks to the strength of our team, the sophistication of our facility, and our commitment to cardiovascular treatment," said Bruce Stec, ASC administrator at Tri-City...
"Delivering more than 6,000...
05/29/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Rolls Out New Radiation Protection System Nova-X® Across EMEA Following Very Promising Clinical Results
05/28/2026
Cathpax has signed several distribution contracts in different geographic regions and is supplying Nova-X® to various neurointerventional centers.
Cathpax has signed several distribution contracts in different geographic regions and is supplying Nova-X® to various neurointerventional centers.
Cathpax has signed several...
05/28/2026
Cath Lab Digest

Subscriber

Cath Lab Digest Newsletter

Clinical & Industry News

Cardiac Amyloidosis
AccurKardia Granted Patent for AI-Driven ECG Detection of Cardiac Amyloidosis
06/04/2026
Only recently recognized as a leading cause of heart failure in older adults, the condition remains widely underdiagnosed.
Only recently recognized as a leading cause of heart failure in older adults, the condition remains widely underdiagnosed.
Only recently recognized as a...
06/04/2026
Cath Lab Digest
SCAI + SCCT Statement
New Consensus Statement Standardizes Use of CT-Derived FFR
06/04/2026
Published in JCCT and endorsed by the ACC, “Fractional flow reserve in coronary computed tomography angiography” provides evidence-based guidelines for the acquisition, interpretation and reporting of FFR-CT.
Published in JCCT and endorsed by the ACC, “Fractional flow reserve in coronary computed tomography angiography” provides evidence-based guidelines for the acquisition, interpretation and reporting of FFR-CT.
Published in JCCT and endorsed...
06/04/2026
Cath Lab Digest
Drug-Coated Balloons
Advanced NanoTherapies Secures Over $31M Series B to Deliver First-of-its-Kind Dual-Drug (Paclitaxel and Sirolimus) Nanoparticle-Coated Balloon Platform for Vascular Treatment
06/02/2026
Advanced NanoTherapies (ANT)'s SirPlux Duo, a dual-drug device with sirolimus and paclitaxel that uses a proprietary nanoparticle delivery system to drive active cellular uptake within the vessel wall.
Advanced NanoTherapies (ANT)'s SirPlux Duo, a dual-drug device with sirolimus and paclitaxel that uses a proprietary nanoparticle delivery system to drive active cellular uptake within the vessel wall.
Advanced NanoTherapies (ANT)'s...
06/02/2026
Cath Lab Digest
ASC 6,000 milestone procedures
Arizona Centers
Arizona-Based Tri-City Cardiology's ASC Surpasses 6,000 Procedures, Marking a Major Milestone in Outpatient Cardiovascular Care
05/29/2026
"Delivering more than 6,000 procedures in an outpatient environment speaks to the strength of our team, the sophistication of our facility, and our commitment to cardiovascular treatment," said Bruce Stec, ASC administrator at Tri-City...
"Delivering more than 6,000 procedures in an outpatient environment speaks to the strength of our team, the sophistication of our facility, and our commitment to cardiovascular treatment," said Bruce Stec, ASC administrator at Tri-City...
"Delivering more than 6,000...
05/29/2026
Cath Lab Digest
Awards
ACC President Roxana Mehran, MD, FACC, Receives Andreas Grüntzig Ethica Award
05/28/2026
The award, named after Andreas Grüntzig, the pioneering German cardiologist who developed the first balloon angioplasty, is the highest honor presented by the Percutaneous Cardiovascular Registry (PCR).
The award, named after Andreas Grüntzig, the pioneering German cardiologist who developed the first balloon angioplasty, is the highest honor presented by the Percutaneous Cardiovascular Registry (PCR).
The award, named after Andreas...
05/28/2026
Cath Lab Digest
Cancer and Heart Disease
CARDIOCARE Project Celebrates Major Advances in Protecting Heart Health of Older Patients With Breast Cancer at Risk of Cardiotoxicity From Cancer Treatment
05/28/2026
Key takeaways: Project combines a wide range of data from more than 2,200 breast cancer patients to help the development of personalised AI-driven tools. Researchers have developed two dedicated applications to monitor both physical...
Key takeaways: Project combines a wide range of data from more than 2,200 breast cancer patients to help the development of personalised AI-driven tools. Researchers have developed two dedicated applications to monitor both physical...
Key takeaways: Project...
05/28/2026
Cath Lab Digest
Radiation Protection Systems
Cathpax Rolls Out New Radiation Protection System Nova-X® Across EMEA Following Very Promising Clinical Results
05/28/2026
Cathpax has signed several distribution contracts in different geographic regions and is supplying Nova-X® to various neurointerventional centers.
Cathpax has signed several distribution contracts in different geographic regions and is supplying Nova-X® to various neurointerventional centers.
Cathpax has signed several...
05/28/2026
Cath Lab Digest
CTO Viability
Rentrop Collateral Grade as an Angiographic Predictor of Myocardial Viability in Chronic Total Occlusion
05/28/2026
Your heart already has its own built-in bypass system that predicts whether the heart muscle is alive or dead, according to new research from the University of East Anglia and Norfolk and Norwich University Hospital. A new study reveals...
Your heart already has its own built-in bypass system that predicts whether the heart muscle is alive or dead, according to new research from the University of East Anglia and Norfolk and Norwich University Hospital. A new study reveals...
Your heart already has its own...
05/28/2026
Cath Lab Digest
Vertex Catheter (Jupiter Endovascular)
Pulmonary Embolism
Jupiter Endovascular Announces Positive Results From SPIRARE II Pivotal Trial at EuroPCR 2026
05/26/2026
The Vertex system leverages the company’s patented Transforming Fixation (TFX) platform technology in a novel catheter system designed to navigate flexibly through the right heart and then stabilize on-demand in the pulmonary arteries for...
The Vertex system leverages the company’s patented Transforming Fixation (TFX) platform technology in a novel catheter system designed to navigate flexibly through the right heart and then stabilize on-demand in the pulmonary arteries for...
The Vertex system leverages the...
05/26/2026
Cath Lab Digest
Uncontrolled Hypertension
AstraZeneca's Baxfendy Approved in U.S. as Aldosterone Synthase Inhibitor Treatment for Adults With Hypertension
05/26/2026
AstraZeneca’s Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive medications, to lower blood...
AstraZeneca’s Baxfendy (baxdrostat) has been approved in the US as a first-in-class aldosterone synthase inhibitor (ASI) for the treatment of hypertension in combination with other antihypertensive medications, to lower blood...
...
05/26/2026
Cath Lab Digest

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use